Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma (RECORD 4)

Sponsors and Collaborators
Novartis Pharmaceuticals

Contact
Novartis Pharmaceuticals
+1-862-778-8300

Principal Investigator
Novartis Pharmaceuticals

ClinicalTrials.gov Identifier
NCT01491672